Evidence map›Paper›PMID 39769415›Full record

ArticleInternational journal of molecular sciences2024

Characterization of Site-Specific N- and O-Glycopeptides from Recombinant Spike and ACE2 Glycoproteins Using LC-MS/MS Analysis.

Ju Hwan Song, Sangeun Jang, Jin-Woong Choi, Seoyoung Hwang, Kyoung Heon Kim, Hye-Yeon Kim, Sun Cheol Park, Wonbin Lee, Ju Yeon Lee

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ju Hwan SongDigital Omics Research Center, Korea Basic Science Institute, Ochang 28119, Republic of Korea.ORCID 0009-0007-7008-5192
Sangeun JangDigital Omics Research Center, Korea Basic Science Institute, Ochang 28119, Republic of Korea.
Jin-Woong ChoiDigital Omics Research Center, Korea Basic Science Institute, Ochang 28119, Republic of Korea.
Seoyoung HwangDigital Omics Research Center, Korea Basic Science Institute, Ochang 28119, Republic of Korea.
Kyoung Heon KimDepartment of Biotechnology, Graduate School, Korea University, Seoul 02841, Republic of Korea.ORCID 0000-0003-4600-8668
Hye-Yeon KimBiopharmaceutical Research Center, Korea Basic Science Institute, Cheongju 28119, Republic of Korea.
Sun Cheol ParkBiopharmaceutical Research Center, Korea Basic Science Institute, Cheongju 28119, Republic of Korea.
Wonbin LeeBiopharmaceutical Research Center, Korea Basic Science Institute, Cheongju 28119, Republic of Korea.
Ju Yeon LeeDigital Omics Research Center, Korea Basic Science Institute, Ochang 28119, Republic of Korea.ORCID 0000-0003-0855-6516

Funding

Korea Basic Science Institute A423100National Research Council of Science and Technology CRC22021-100National Research Foundation of Korea 2021M3E5D3016632National Research Foundation of Korea RS-2024-00454407
6 · The paper itself

Abstract

The COVID-19 pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has resulted in hundreds of millions of infections and millions of deaths globally. Although vaccination campaigns are mitigating the pandemic, emerging viral variants continue to pose challenges. The spike (S) protein of SARS-CoV-2 plays a critical role in viral entry by binding to the angiotensin-converting enzyme 2 (ACE2) receptor, making both proteins essential targets for therapeutic and vaccine development. The glycosylation of these proteins influences their structure and function. This underscores the need for detailed site-specific glycoproteomic analysis. In this study, we characterized the N- or O-glycosylation profiles of the recombinant receptor-binding domain (RBD) of spike protein and ACE2 proteins expressed from Expi293F cells, as well as the S2 subunit of spike protein expressed in plant (

Indexed as

Angiotensin-Converting Enzyme 2GlycopeptidesRecombinant ProteinsSpike Glycoprotein, CoronavirusTandem Mass SpectrometryChromatography, LiquidCOVID-19GlycosylationHumansLiquid Chromatography-Mass SpectrometryPeptidyl-Dipeptidase APolysaccharidesSARS-CoV-2ACE2 protein, humanAngiotensin-Converting Enzyme 2GlycopeptidesPeptidyl-Dipeptidase APolysaccharidesRecombinant ProteinsSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2LC-MS/MS analysismodification of glycanreaction-binding domainrecombinant proteinssite-specific glycopeptidesspike glycoprotein

Identifiers

PMID39769415
PMCPMC11678118

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.